Culture Amp, an employee feedback platform, has raised $40 million in Series D funding, according to a blog post on its site. Blackbird Ventures led the round with participation from other investors that included Felicis Ventures, Index Ventures, Sapphire Ventures, Skip Capital and Grok Ventures.
1 min read · 19 July 2018
Revibe Technologies, a wearable tech firm, has raised an undisclosed amount of funding. MHS led the round with participation from other investors that included CoFounders Capital, Bootstrap Advisors, BioVenture Partners, Tamiami Angel Fund, Charlotte Angel Fund, RTP Capital and Blount Street Capital. As part of the transaction, MHS President Hazel Wheldon has joined the Revibe Technologies’ board of directors.
1 min read · 19 July 2018
Ridgefield Connecticut-based R4 Technologies, an artificial intelligence startup, has secured $20 million in Series B funding. Pilot Growth Equity led the round.
3 min read · 18 July 2018
The JDRF T1D Fund, a venture philanthropy fund focused on type 1 diabetes, has named Katie Ellias as managing director. Previously, Ellias worked at Endeavour Vision where she was a senior investment director.
3 min read · 18 July 2018
Elizabethtown, Kentucky-based Venminder, the financial services industry’s solution for third party risk management, has secured $5 million in Series B follow-on financing. MissionOG led the round with participation from other investors that included Bain Capital Ventures.
1 min read · 18 July 2018
Washington, D.C.-based Framebridge, a direct-to-consumer custom framing company, has secured $30 million in Series C funding, according to a blog post. T. Rowe Price led the round.
1 min read · 18 July 2018
Texas-based Service Fusion, a field service management software provider, has secured $10 million in Series A funding. The investor was Five Elms Capital.
1 min read · 18 July 2018
Lygos Inc, a creator of new biology based products, has raised $15.5 million in Series B financing. IA Ventures and First Round Capital led the round with participation from Y Combinator Continuity Fund and OS Fund.
1 min read · 18 July 2018
San Diego-based Crinetics Pharmaceuticals, a drug developer focused on rare endocrine diseases and endocrine-related tumors, has raised $102 million for its IPO after pricing its 6 million shares at $17 per share. The stock began trading July 18, 2018 on the NASDAQ under the ticker symbol "CRNX." J.P. Morgan Securities LLC, Leerink Partners LLC and Piper Jaffray & Co are the lead underwriters. Crinetics' pre-IPO backers include Versant Ventures, 5AM Ventures and Vivo Capital.
3 min read · 18 July 2018
Los Angeles-based Openpath, a provider of smart, secure access systems for the modern office, has raised $20 million in Series B funding. Emergence Capital led the round.
1 min read · 18 July 2018
